vimarsana.com

Latest Breaking News On - Institutional investors weigh in on aurinia pharmaceuticals - Page 1 : vimarsana.com

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Short Interest Down 12 0% in March

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 10,650,000 shares, a decrease of 12.0% from the February 29th total of 12,100,000 shares. Based on an average daily trading volume, of […]

Aurinia Pharmaceuticals (NASDAQ:AUPH) Price Target Cut to $13 00

Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) had its price target reduced by stock analysts at HC Wainwright from $15.00 to $13.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price target suggests a potential […]

Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 52-Week Low Following Weak Earnings

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) shares reached a new 52-week low during trading on Thursday after the company announced weaker than expected quarterly earnings. The company traded as low as $5.50 and last traded at $5.91, with a volume of 6703556 shares traded. The stock had previously closed at $7.97. The […]

Aurinia Pharmaceuticals (NASDAQ:AUPH) Trading 4% Higher

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was up 4% during mid-day trading on Wednesday . The company traded as high as $10.20 and last traded at $10.19. Approximately 1,353,016 shares changed hands during trading, a decline of 52% from the average daily volume of 2,817,593 shares. The stock had previously closed at […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.